Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 28Genitourinary 13Breast 12Thoracic 8Other solid neoplasm 8Dermatologic 5Sarcoma 4Plasma cell 4Other hematologic neoplasm 4Tumor-Agnostic 3Gynecologic 3CNS 3Myeloid 2Lymphoid 2Other 1Head & Neck 1

Conditions

Neoplasms 2Adenocarcinoma 1

Interventions

pembrolizumab 94Paclitaxel 85Gemcitabine 83Carboplatin 79Docetaxel 60Cisplatin 58Bevacizumab 58Nivolumab 56Fluorouracil 47Capecitabine 46Magnetic Resonance Spectroscopy 44Radiotherapy 41Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 37Pemetrexed 34Leucovorin 34Biopsy 34atezolizumab 33Cetuximab 32Standard of Care 31Trastuzumab 28Cyclophosphamide 28Radiosurgery 27Blood Specimen Collection 27Specimen Handling 26Sorafenib 26Ipilimumab 26Everolimus 26olaparib 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Hydroxychloroquine × Tumor-Agnostic × Clear all
NCT01506973 2025-07-25

A Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane in Pancreatic Cancer

Abramson Cancer Center at Penn Medicine

Phase 1/2 Completed
119 enrolled
Tumor-Agnostic

Adenocarcinoma

NCT02232243 2021-06-28

HCQ on PAR-4 Levels in Patients With Resectable Solid Tumors

University of Kentucky

Phase 1 Completed
10 enrolled 9 charts
Tumor-Agnostic

Neoplasms

NCT01266057 2021-03-04

Sirolimus or Vorinostat and Hydroxychloroquine in Advanced Cancer

M.D. Anderson Cancer Center

Phase 1 Completed
143 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡